Nanoparticle-Based Drug Delivery Systems for Enhancing Bone Regeneration
Source abstract
Abstract
The treatment of bone defects has been a long-standing challenge in clinical practice. Among the various bone tissue engineering approaches, there has been substantial progress in the development of drug delivery systems based on functional drugs and appropriate carrier materials owing to technological advances in recent years. A large number of materials based on functional nanocarriers have been developed and applied to improve the complex osteogenic microenvironment, including for promoting osteogenic activity, inhibiting osteoclast activity, and exerting certain antibacterial effects. This Review discusses the physicochemical properties, drug loading mechanisms, advantages and disadvantages of nanoparticles (NPs) used for constructing drug delivery systems. In addition, we provide an overview of the osteogenic microenvironment regulation mechanism of drug delivery systems based on nanoparticle (NP) carriers and the construction strategies of drug delivery systems. Finally, the advantages and disadvantages of NP carriers are summarized along with their prospects and future research trends in bone tissue engineering. This Review thus provides advanced strategies for the design and application of drug delivery systems based on NPs in the treatment of bone defects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Bone Tissue Engineering Materials · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, P. R. China
Funding
Department of Science and Technology of Jilin Province · Jilin Province Development and Reform Commission · Education Department of Jilin Province
References (100+)
Show source-provided references
1. 10.1016/j.jsamd.2020.01.00710.1016/j.jsamd.2020.01.007 ↗
2. 10.1186/1741-7015-9-6610.1186/1741-7015-9-66 ↗
3. 10.1186/1749-799X-9-1810.1186/1749-799X-9-18 ↗
4. 10.3390/ph1507087910.3390/ph15070879 ↗
5. Athanasiou V. T. · Medical Science Monitor · 2010 · 16 · BR24
6. 10.1039/D2TB01684B10.1039/D2TB01684B ↗
7. 10.1126/scitranslmed.aad590410.1126/scitranslmed.aad5904 ↗
8. 10.1039/C9RA05214C10.1039/C9RA05214C ↗
9. 10.1016/j.cej.2014.06.02210.1016/j.cej.2014.06.022 ↗
10. 10.3390/coatings1210138010.3390/coatings12101380 ↗
11. 10.1016/j.actbio.2016.06.02310.1016/j.actbio.2016.06.023 ↗
12. 10.1016/S0939-6411(00)00087-410.1016/S0939-6411(00)00087-4 ↗
13. 10.1016/j.arabjc.2017.05.01110.1016/j.arabjc.2017.05.011 ↗
14. 10.3390/nano911157010.3390/nano9111570 ↗
15. 10.1016/j.actbio.2022.04.01410.1016/j.actbio.2022.04.014 ↗
16. 10.1002/jbm.a.3453910.1002/jbm.a.34539 ↗
17. 10.1002/smll.20220146210.1002/smll.202201462 ↗
18. 10.1039/C4TB00339J10.1039/C4TB00339J ↗
19. 10.1016/j.biomaterials.2021.12110410.1016/j.biomaterials.2021.121104 ↗
20. 10.1155/2021/376249010.1155/2021/3762490 ↗
21. 10.1080/09168451.2018.156287510.1080/09168451.2018.1562875 ↗
22. 10.1039/C4CC08914F10.1039/C4CC08914F ↗
23. 10.1021/ja028650l10.1021/ja028650l ↗
24. 10.1016/j.jconrel.2016.09.03210.1016/j.jconrel.2016.09.032 ↗
25. 10.1039/C7NR08430G10.1039/C7NR08430G ↗
26. 10.1016/j.bbrc.2022.02.08010.1016/j.bbrc.2022.02.080 ↗
27. 10.2147/IJN.S8879810.2147/IJN.S88798 ↗
28. 10.1021/ja210771m10.1021/ja210771m ↗
29. 10.3390/pharmaceutics1310164210.3390/pharmaceutics13101642 ↗
30. 10.1016/j.cis.2020.10215710.1016/j.cis.2020.102157 ↗
31. 10.2147/DDDT.S29964110.2147/DDDT.S299641 ↗
32. 10.1016/j.actbio.2008.07.02310.1016/j.actbio.2008.07.023 ↗
33. 10.1016/j.actbio.2009.10.03110.1016/j.actbio.2009.10.031 ↗
34. 10.1016/j.actbio.2008.09.02210.1016/j.actbio.2008.09.022 ↗
35. 10.1016/j.jconrel.2017.02.01210.1016/j.jconrel.2017.02.012 ↗
36. 10.1002/cphc.20120008010.1002/cphc.201200080 ↗
37. 10.1016/j.actbio.2019.01.06010.1016/j.actbio.2019.01.060 ↗
38. 10.1016/j.jconrel.2014.12.03410.1016/j.jconrel.2014.12.034 ↗
39. 10.1021/acsami.6b0818010.1021/acsami.6b08180 ↗
40. 10.1038/s41598-021-93367-610.1038/s41598-021-93367-6 ↗
41. 10.1002/jbm.b.3468810.1002/jbm.b.34688 ↗
42. 10.3389/fchem.2021.72418810.3389/fchem.2021.724188 ↗
43. 10.2147/IJN.S28224610.2147/IJN.S282246 ↗
44. 10.1039/C8NR04037K10.1039/C8NR04037K ↗
45. 10.1038/srep2733610.1038/srep27336 ↗
46. 10.1080/14686996.2019.164419310.1080/14686996.2019.1644193 ↗
47. 10.1039/C1CS15166E10.1039/C1CS15166E ↗
48. 10.2217/17435889.4.1.8310.2217/17435889.4.1.83 ↗
49. Tran, N.; Pareta, R.; Taylor, E.; Webster, T. J. In Iron Oxide Nanoparticles: Novel Drug Delivery Materials for Treating Bone Diseases; 6th International Conference on Processing and Manufacturing of Advanced Materials (THERMEC)/2nd Symposium Session on Multiscale Mechanical Modelling of Complex Materials and Engineering Applications, Berlin, GERMANY, Aug 25–29; Berlin, GERMANY, 2009; pp 411.
50. 10.3390/ma1604142910.3390/ma16041429 ↗
51. 10.1016/j.ijpharm.2018.10.02310.1016/j.ijpharm.2018.10.023 ↗
52. 10.1186/s12868-017-0369-910.1186/s12868-017-0369-9 ↗
53. 10.3390/ma1408186410.3390/ma14081864 ↗
54. 10.1016/j.colsurfb.2015.12.00410.1016/j.colsurfb.2015.12.004 ↗
55. 10.1016/j.msec.2019.03.09110.1016/j.msec.2019.03.091 ↗
56. 10.1016/j.actbio.2023.04.04610.1016/j.actbio.2023.04.046 ↗
57. 10.1186/s12951-022-01315-x10.1186/s12951-022-01315-x ↗
58. 10.1021/cm402592t10.1021/cm402592t ↗
59. 10.1016/j.addr.2008.03.01210.1016/j.addr.2008.03.012 ↗
60. 10.1038/s41598-020-66939-110.1038/s41598-020-66939-1 ↗
61. 10.1007/s12603-014-0555-810.1007/s12603-014-0555-8 ↗
62. 10.1007/s12011-012-9593-410.1007/s12011-012-9593-4 ↗
63. 10.1177/153537022199707210.1177/1535370221997072 ↗
64. 10.1016/j.nano.2019.10204010.1016/j.nano.2019.102040 ↗
65. 10.1021/ar200025910.1021/ar2000259 ↗
66. 10.1021/ja102226710.1021/ja1022267 ↗
67. 10.1021/ja110094g10.1021/ja110094g ↗
68. 10.1021/ja105371u10.1021/ja105371u ↗
69. 10.1155/2022/838545610.1155/2022/8385456 ↗
70. 10.1016/j.nano.2011.11.00310.1016/j.nano.2011.11.003 ↗
71. 10.1016/j.micromeso.2020.11068710.1016/j.micromeso.2020.110687 ↗
72. 10.1088/1748-605X/12/1/01500110.1088/1748-605X/12/1/015001 ↗
73. 10.3389/fcimb.2023.112441110.3389/fcimb.2023.1124411 ↗
74. 10.3390/bioengineering810013710.3390/bioengineering8100137 ↗
75. 10.1080/1061186X.2021.202316010.1080/1061186X.2021.2023160 ↗
76. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
77. 10.1016/j.addr.2021.11385110.1016/j.addr.2021.113851 ↗
78. 10.1016/j.nano.2018.06.00110.1016/j.nano.2018.06.001 ↗
79. 10.1080/08982104.2023.228597310.1080/08982104.2023.2285973 ↗
80. 10.3390/cancers1501000410.3390/cancers15010004 ↗
81. 10.1007/s13205-020-2142-510.1007/s13205-020-2142-5 ↗
82. 10.1007/s13346-018-0561-110.1007/s13346-018-0561-1 ↗
83. 10.1080/10837450.2020.179845810.1080/10837450.2020.1798458 ↗
84. 10.2217/nnm.15.1110.2217/nnm.15.11 ↗
85. 10.1007/s12274-018-2152-310.1007/s12274-018-2152-3 ↗
86. 10.1016/j.jconrel.2017.01.04710.1016/j.jconrel.2017.01.047 ↗
87. 10.2217/nnm-2016-034010.2217/nnm-2016-0340 ↗
88. 10.1177/096739112091365810.1177/0967391120913658 ↗
89. 10.1016/j.carbpol.2020.11706310.1016/j.carbpol.2020.117063 ↗
90. 10.3390/biom501000310.3390/biom5010003 ↗
91. 10.1038/srep3182210.1038/srep31822 ↗
92. 10.1038/mt.2008.9910.1038/mt.2008.99 ↗
93. 10.1007/s12033-014-9816-310.1007/s12033-014-9816-3 ↗
94. 10.1016/j.carbpol.2021.11907710.1016/j.carbpol.2021.119077 ↗
95. 10.1016/j.bej.2021.10813810.1016/j.bej.2021.108138 ↗
96. 10.1016/j.jddst.2023.10462710.1016/j.jddst.2023.104627 ↗
97. 10.1016/j.msec.2020.11069810.1016/j.msec.2020.110698 ↗
98. 10.1002/jor.2039110.1002/jor.20391 ↗
99. 10.3390/molecules2102020710.3390/molecules21020207 ↗
100. 10.3389/fbioe.2021.60360810.3389/fbioe.2021.603608 ↗